| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/12/2005 | US20050101530 Cellular virus receptors and methods of use |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050101016 Recovering autoantibodies/blood protein via adjustment in redox states for use in constructing profile for diagnosing autoimmune disorders |
| 05/12/2005 | US20050100984 Expression vector comprising nucleotide sequences coding immunoglobulin fusion directed towards tumors for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy; immunotherapy |
| 05/12/2005 | US20050100979 Using non-selenium glutathione peroxidase protein concentrations as diagnostic/prognostic tool in detection of neurodegenerative disorders |
| 05/12/2005 | US20050100965 IL-18 binding proteins |
| 05/12/2005 | US20050100962 Detection of prion disease |
| 05/12/2005 | US20050100957 Hybridoma cell lines for use in propagation of monoclonal antibodies for prevention and treatment of cell proliferative disorders; immunotherapy |
| 05/12/2005 | US20050100955 Immunoglobulin direceted towards colon specific gene (CSG) for use in classification, treatment and prevention of cell proliferative disorders; diagnostic imaging; gene expression inhibition; immunotherapy |
| 05/12/2005 | US20050100952 Transgenic mammalian cells for use as bioreactors in expression of heterologous gene sequences |
| 05/12/2005 | US20050100940 Novel FDRG protein and nucleic acid molecules and uses therefor |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100913 RNA interference pathway genes as tools for targeted genetic interference |
| 05/12/2005 | US20050100894 Novel mitogen activated kinase |
| 05/12/2005 | US20050100885 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 05/12/2005 | US20050100882 Viral polypeptide fusion comprising guanylyltransferase, methyltransferase and polymerase activities for use as tool in identifying modulator of viral propagation; viricides |
| 05/12/2005 | US20050100555 Synovial tissue binding peptide; amino acid sequence motifs; identify binding peptides by grafting tissue of first species into second having attenuated immunological response |
| 05/12/2005 | US20050100554 Chimeric polypeptides, vectors and cells; test for precancerous cells; human papilloma virus |
| 05/12/2005 | US20050100551 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells |
| 05/12/2005 | US20050100550 Anti-angiogenic uses of IL-6 antagonists |
| 05/12/2005 | US20050100548 BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| 05/12/2005 | US20050100546 Human monoclonal antibodies to epidermal growth factor receptor |
| 05/12/2005 | US20050100545 Mutated antibody does not possess O-linked glycosylation, nucleic acids encoding prevents N-linked glycosylation; humanized and conjugated with radionucleotide to image target cells |
| 05/12/2005 | US20050100544 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 05/12/2005 | US20050100543 Multivalent carriers of bi-specific antibodies |
| 05/12/2005 | US20050100542 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/12/2005 | US20050100541 Ligands, including antibodies, showing reactivity against endocrine cells |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | CA2544708A1 Liver cancer biomarkers |
| 05/12/2005 | CA2544365A1 Modified anti-cd52 antibody |
| 05/12/2005 | CA2543763A1 Bacterial virulence factors and uses thereof |
| 05/12/2005 | CA2543703A1 Psma formulations and uses thereof |
| 05/12/2005 | CA2543125A1 Colostrum compositions and methods |
| 05/12/2005 | CA2543093A1 Therapeutic regimens for baff antagonists |
| 05/12/2005 | CA2542840A1 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis |
| 05/12/2005 | CA2541846A1 A protein involved in ovarian cancer |
| 05/12/2005 | CA2539576A1 Method for linking sequences of interest |
| 05/12/2005 | CA2536238A1 Humanization of antibodies |
| 05/12/2005 | CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/11/2005 | EP1529063A1 Antibodies anti-c5 component of the complement system and their use |
| 05/11/2005 | EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 05/11/2005 | EP1529060A2 Method for the production of an immunostimulating mucin (muc1) |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1528936A1 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer |
| 05/11/2005 | EP1528935A1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
| 05/11/2005 | EP1528934A1 Use of antibodies against a tumor-associated antigen |
| 05/11/2005 | EP1487967A4 Chimeric pancreas |
| 05/11/2005 | EP1248802B9 Soluble ctla4 mutant molecules and uses thereof |
| 05/11/2005 | EP1187633A4 Use of anti-vegf antibody to enhance radiation in cancer therapy |
| 05/11/2005 | EP1161153B1 Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 05/11/2005 | EP1159620B1 Detection of mtoc disrupting substances |
| 05/11/2005 | EP1105426B1 Monoclonal antibody inhibitor of gm-csf, il-3, il-5 and other cytokines, and uses thereof |
| 05/11/2005 | EP1088069B1 Angiostatin-binding protein |
| 05/11/2005 | EP1062364B1 Qualitative differential screening |
| 05/11/2005 | EP0993470B1 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 05/11/2005 | EP0944725B1 Phosphodiesterase 8 |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | EP0625200B1 Biosynthetic binding protein for cancer marker |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615316A Novel immunogenic mimetics of multimer proteins |
| 05/11/2005 | CN1615315A Tumor specific monoclonal antibodies |
| 05/11/2005 | CN1613874A Human tumour necrosin antibody, its preparation and medicinal composition |
| 05/11/2005 | CN1613873A Anti-cancer surface antigen of p185 monoantigen embedded antibody and its preparation |
| 05/11/2005 | CN1201150C Composite, chemical luminescent system and its applications |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/11/2005 | CN1201003C Adipocyte-specific protein homologs |
| 05/11/2005 | CN1200950C Immuno-conjugated compound as protein or nucleic acid trasnferring carrier |
| 05/11/2005 | CN1200734C Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 05/11/2005 | CN1200733C Reversal of viral-induced systemic shock and respiratory distress by blockade of lymphotoxin beta pathway |
| 05/11/2005 | CN1200731C Derivatives of pneumococcal choline binding proteins for vaccines |
| 05/10/2005 | US6891028 Nucleic acids encoding transferrin receptor-like proteins |
| 05/10/2005 | US6891024 Monoclonal antibodies to Sarcocystis neurona and uses therefor |
| 05/10/2005 | US6891023 Antibodies and Fv fragment recognizing antigen IOR C2 |
| 05/10/2005 | US6891022 SH2-containing proteins (Nsp's) for diagnosis/treatment/ prevention of mammalian tumors; solid phase synthesis; kits; drugs |
| 05/10/2005 | US6890899 A lipolytic or lipid mobilising factor (LMF) produced by the cachexia-inducing murine tumor MAC16; weight reduction or controlling obesity; administering a Zn-alpha 2-glycoprotein |
| 05/10/2005 | US6890753 Culturing preferential lymphocytes; obtain lymphocytes, inoculate nutrint broth, propagate, recover cells |
| 05/10/2005 | US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/10/2005 | US6890731 For drug screeing/therapy of diseases; bacteriophages |
| 05/10/2005 | US6890724 Antibody for use in the treatment of barre-guillaum syndrome |
| 05/10/2005 | US6890722 HP biopolymer markers predictive of insulin resistance |
| 05/10/2005 | US6890717 For diagnostics/screening assays/hybridization probes/primers/therapy for osteoporosis/periodontal disease |
| 05/10/2005 | US6890554 Genetic immunization with cationic lipids |
| 05/10/2005 | US6890536 Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications |
| 05/10/2005 | US6890535 Pharmaceutical compositions and methods for treatment of amyloid diseases |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | US6890532 Postexposure prophylaxis therapy |
| 05/10/2005 | CA2330935C A mutant human hepatitis b viral strain and uses thereof |
| 05/10/2005 | CA2116559C Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005040815A1 Method of detecting hepatitis c virus |
| 05/06/2005 | WO2005040395A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 05/06/2005 | WO2005040386A2 A vector modification for versatile use of expressed products |
| 05/06/2005 | WO2005040338A2 Constrained alkaloid immunogens and antibodies and uses thereof |
| 05/06/2005 | WO2005040222A1 Monoclonal antibodies for detection of urinary trypsin inhibitors |
| 05/06/2005 | WO2005040221A1 Correlation between the fucose content / galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 05/06/2005 | WO2005040220A1 Multispecific deimmunized cd3-binders |
| 05/06/2005 | WO2005040219A1 Laminin-5 gamma2-binding peptides, related compositions, and use thereof |